isoproterenol has been researched along with Wolff-Parkinson-White Syndrome in 58 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thirteen patients had sustained orthodromic supraventricular tachycardia induced during baseline study, and two patients needed isoproterenol to render it sustained." | 9.06 | Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome. ( Campa, MA; Dubuc, M; Kus, T; Lambert, C; Rosengarten, M; Shenasa, M, 1989) |
| "In order to evaluate the effects of increases of sympathetic tone in ventricular response during atrial fibrillation and in the relationship between the accessory pathway effective refractory period (ERP) and ventricular rate during atrial fibrillation, 20 male subjects, aged 19 +/- 6 years, were studied electrophysiologically in basal conditions, after isoproterenol infusion (2-4 micrograms/min) and during submaximal bicycle exercise test, at a constant workload equal to that which increases the sinus rate to the same extent (140 beats/min) induced by isoproterenol infusion." | 7.68 | Comparison of isoproterenol and exercise tests in asymptomatic subjects with Wolff-Parkinson-White syndrome. ( Chimienti, M; Klersy, C; Li Bergolis, M; Moizi, M; Negroni, MS; Salerno, JA, 1992) |
| "Isoproterenol and/or atropine allowed tachycardia induction in four of 18 asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern." | 7.68 | Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern. ( Kim, YH; Klein, GJ; Leather, RA; Leitch, JW; Yee, R, 1992) |
| "The ultrashort-acting beta blocker flestolol was studied during atrial pacing and atrial fibrillation (AF) in 10 patients with Wolff-Parkinson-White syndrome." | 7.67 | Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome. ( Liem, LB; Peterson, J; Swerdlow, CD, 1988) |
| "The effects of exercise and isoproterenol on atrial fibrillation (AF) were studied in 17 patients with Wolff-Parkinson-White syndrome (WPW) to assess the risk of developing a rapid ventricular response." | 7.66 | Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. ( Broughton, A; Gallagher, JJ; German, LD; Guarnieri, T; Trantham, JL, 1983) |
| "Sotalol has Class II and III antiarrhythmic effects." | 5.28 | Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol. ( Madrid, AH; Maŕin Huerta, EM; Mestre, JL; Moro, C; Novo, L, 1992) |
| "Isoproterenol infusion was given in dosages of 1 to 4 micrograms/min to increase the heart rate at rest by 50%." | 5.28 | Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome. ( Estes, NA; Manolis, AS, 1989) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 5.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| " Thirteen patients had sustained orthodromic supraventricular tachycardia induced during baseline study, and two patients needed isoproterenol to render it sustained." | 5.06 | Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome. ( Campa, MA; Dubuc, M; Kus, T; Lambert, C; Rosengarten, M; Shenasa, M, 1989) |
| "In order to evaluate the effects of increases of sympathetic tone in ventricular response during atrial fibrillation and in the relationship between the accessory pathway effective refractory period (ERP) and ventricular rate during atrial fibrillation, 20 male subjects, aged 19 +/- 6 years, were studied electrophysiologically in basal conditions, after isoproterenol infusion (2-4 micrograms/min) and during submaximal bicycle exercise test, at a constant workload equal to that which increases the sinus rate to the same extent (140 beats/min) induced by isoproterenol infusion." | 3.68 | Comparison of isoproterenol and exercise tests in asymptomatic subjects with Wolff-Parkinson-White syndrome. ( Chimienti, M; Klersy, C; Li Bergolis, M; Moizi, M; Negroni, MS; Salerno, JA, 1992) |
| "Isoproterenol and/or atropine allowed tachycardia induction in four of 18 asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern." | 3.68 | Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern. ( Kim, YH; Klein, GJ; Leather, RA; Leitch, JW; Yee, R, 1992) |
| "The ultrashort-acting beta blocker flestolol was studied during atrial pacing and atrial fibrillation (AF) in 10 patients with Wolff-Parkinson-White syndrome." | 3.67 | Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome. ( Liem, LB; Peterson, J; Swerdlow, CD, 1988) |
| "Reversal of the electrophysiologic effects of oral encainide with isoproterenol was evaluated in 16 patients with atrioventricular (AV) nodal reentry (group A) and in another 16 patients with Wolff-Parkinson-White syndrome (group B)." | 3.67 | Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia. ( Akhtar, M; Dougherty, AH; Jazayeri, M; Naccarelli, GV; Niazi, I; Rinkenberger, R; Tchou, P, 1988) |
| "The effects of exercise and isoproterenol on atrial fibrillation (AF) were studied in 17 patients with Wolff-Parkinson-White syndrome (WPW) to assess the risk of developing a rapid ventricular response." | 3.66 | Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. ( Broughton, A; Gallagher, JJ; German, LD; Guarnieri, T; Trantham, JL, 1983) |
| "Out of 33 patients with WPW syndrome, 10 (group I) had a clinical history of severe arrhythmia and 23 (group II) were asymptomatic or had paroxysmal nodal tachycardia." | 2.37 | [Should the Isuprel test be performed systematically in Wolff-Parkinson-White syndrome?]. ( Brembilla-Perrot, B; Cherrier, F; Marçon, F; Pernot, C; Terrier de la Chaise, A, 1988) |
| "This is a rare case of antidromic reciprocating tachycardia developing 8 years after successful catheter ablation." | 1.35 | Decremental accessory pathway conduction after ablation and antidromic atrioventricular reciprocating tachycardia 8 years after successful radiofrequency ablation. ( Fukuhara, J; Mugishima, H; Sugi, K; Sumitomo, N, 2009) |
| "Isoproterenol was not required in five children younger than 10 years old, because they developed a catecholaminergic sinus tachycardia." | 1.34 | Interest of non-invasive and semi-invasive testings in asymptomatic children with pre-excitation syndrome. ( Abbas, M; Ammar, S; Bertrand, J; Beurrier, D; Brembilla-Perrot, B; Cedano, J; Chometon, F; Cloez, JL; Duhoux, F; Groben, L; Huttin, O; Marcha, C; Marçon, F; Tatar, C; Terrier de Chaise, A; Tisserand, A; Yangni N'da, O; Zhang, N, 2007) |
| "In patients with WPW syndrome, 15 had a potentially malignant form with the induction of a tachycardia conducted through the accessory pathway at a high rate (> 240/min in control state, > 300/min with isoproterenol); radiofrequency catheter ablation was indicated in a second time." | 1.33 | [Respective interest of two techniques of electrophysiological study in patient without heart disease]. ( Brembilla-Perrot, B, 2006) |
| "We report the case of a man with the WPW syndrome who presented for repeat electrophysiological study and catheter ablation." | 1.32 | Catecholamine dependent accessory pathway automaticity. ( Scheinman, MM; Tseng, ZH; Yadav, AV, 2004) |
| "The coexistence of WPW syndrome and cathecolamine sensitive ventricular tachycardia originating from the RVOT has rarely been reported." | 1.30 | AV reentrant and idiopathic ventricular double tachycardias: complicated interactions between two tachycardias. ( Aizawa, Y; Niwano, S; Tsuchida, K; Washizuka, T, 1999) |
| "Sotalol has Class II and III antiarrhythmic effects." | 1.28 | Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol. ( Madrid, AH; Maŕin Huerta, EM; Mestre, JL; Moro, C; Novo, L, 1992) |
| "Isoproterenol infusion was given in dosages of 1 to 4 micrograms/min to increase the heart rate at rest by 50%." | 1.28 | Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome. ( Estes, NA; Manolis, AS, 1989) |
| "When the risk of potentially serious arrhythmia appears to be confirmed, catheter ablation of the accessory pathway may be the ideal solution, as it may cure the disease without the sequelae inherent in surgery." | 1.28 | [Wolf-Parkinson-White syndrome. Intensive physical activity: the value of fulguration]. ( Haissaguerre, M; Le Métayer, P; Montserrat, P; Warin, JF, 1989) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 1.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "In a patient with transient WPW syndrome the electrocardiographic pattern of preexcitation could repeatedly be induced by carotid sinus massage during isoprenaline infusion." | 1.26 | Manifestation of the Wolff-Parkinson-White syndrome during isoprenaline infusion and carotid sinus massage. ( Gavrilescu, S, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (51.72) | 18.7374 |
| 1990's | 15 (25.86) | 18.2507 |
| 2000's | 5 (8.62) | 29.6817 |
| 2010's | 6 (10.34) | 24.3611 |
| 2020's | 2 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Di Pino, A | 6 |
| Oreto, L | 3 |
| Magnano, M | 1 |
| Bissolino, A | 1 |
| Bocchino, PP | 1 |
| Kubuš, P | 1 |
| Vít, P | 1 |
| Gebauer, RA | 1 |
| Materna, O | 1 |
| Janoušek, J | 1 |
| Cohen, M | 1 |
| Triedman, J | 1 |
| Benson, DW | 1 |
| Cohen, MI | 1 |
| Sumitomo, N | 1 |
| Fukuhara, J | 1 |
| Mugishima, H | 1 |
| Sugi, K | 1 |
| Aleong, RG | 1 |
| Singh, SM | 1 |
| Levinson, JR | 1 |
| Milan, DJ | 1 |
| Moore, JP | 1 |
| Kannankeril, PJ | 1 |
| Fish, FA | 1 |
| Pass, RH | 1 |
| Ceresnak, SR | 1 |
| Gemma, LW | 1 |
| Steinberg, LA | 1 |
| Prystowsky, EN | 1 |
| Padanilam, BJ | 1 |
| Tseng, ZH | 1 |
| Yadav, AV | 1 |
| Scheinman, MM | 1 |
| Brembilla-Perrot, B | 7 |
| Chometon, F | 1 |
| Groben, L | 1 |
| Ammar, S | 1 |
| Bertrand, J | 1 |
| Marcha, C | 1 |
| Cloez, JL | 1 |
| Tisserand, A | 1 |
| Huttin, O | 1 |
| Tatar, C | 1 |
| Duhoux, F | 1 |
| Yangni N'da, O | 1 |
| Beurrier, D | 1 |
| Terrier de Chaise, A | 1 |
| Zhang, N | 1 |
| Abbas, M | 1 |
| Cedano, J | 1 |
| Marçon, F | 2 |
| Wellens, HJ | 1 |
| Brugada, P | 1 |
| Abdollah, H | 1 |
| Horio, Y | 1 |
| Matsuyama, K | 1 |
| Morikami, Y | 1 |
| Rokutanda, M | 1 |
| Hirata, A | 1 |
| Okumura, K | 2 |
| Takaoka, K | 1 |
| Uchida, H | 1 |
| Kugiyama, K | 1 |
| Araki, S | 1 |
| German, LD | 1 |
| Gallagher, JJ | 1 |
| Broughton, A | 1 |
| Guarnieri, T | 1 |
| Trantham, JL | 1 |
| Maia, IG | 1 |
| Sá, Rda S | 1 |
| Drumond Neto, C | 1 |
| Studart, PC | 1 |
| Amino, JG | 1 |
| Peixoto, EC | 1 |
| Dohmann, HJ | 1 |
| da Silveira, WG | 1 |
| Przybylski, J | 1 |
| Chiale, PA | 1 |
| Halpern, MS | 1 |
| Nau, GJ | 1 |
| Elizari, MV | 1 |
| Rosenbaum, MB | 1 |
| Wienecke, M | 1 |
| Case, C | 1 |
| Buckles, D | 1 |
| Gillette, P | 1 |
| Yamabe, H | 1 |
| Yasue, H | 1 |
| Chen, SA | 1 |
| Chiang, CE | 1 |
| Tai, CT | 1 |
| Lee, SH | 1 |
| Chiou, CW | 1 |
| Ueng, KC | 1 |
| Wen, ZC | 1 |
| Cheng, CC | 1 |
| Chang, MS | 1 |
| Panotopoulos, P | 1 |
| Deshpande, S | 1 |
| Akhtar, M | 2 |
| Jazayeri, MR | 1 |
| Washizuka, T | 1 |
| Niwano, S | 2 |
| Tsuchida, K | 1 |
| Aizawa, Y | 2 |
| Nikitin, IuP | 1 |
| Leopa, NA | 1 |
| Gavrilescu, S | 1 |
| Madrid, AH | 1 |
| Moro, C | 1 |
| Maŕin Huerta, EM | 1 |
| Novo, L | 1 |
| Mestre, JL | 1 |
| Manolis, AS | 2 |
| Katsaros, C | 1 |
| Cokkinos, DV | 1 |
| Suzuki, F | 1 |
| Harada, TO | 1 |
| Nawata, H | 1 |
| Ohtomo, K | 1 |
| Satoh, T | 1 |
| Hirao, K | 1 |
| Hiejima, K | 1 |
| Chimienti, M | 2 |
| Li Bergolis, M | 1 |
| Moizi, M | 1 |
| Klersy, C | 2 |
| Negroni, MS | 1 |
| Salerno, JA | 2 |
| Kim, YH | 1 |
| Leitch, JW | 1 |
| Klein, GJ | 2 |
| Yee, R | 2 |
| Leather, RA | 1 |
| Ghawi, R | 1 |
| Dechaux, JP | 1 |
| Goy, JJ | 1 |
| Fromer, M | 1 |
| Schlaepfer, J | 1 |
| Kappenberger, L | 1 |
| Spatz, F | 1 |
| Khaldi, E | 1 |
| Terrier de la Chaise, A | 2 |
| Suty-Selton, C | 1 |
| Le Van, D | 1 |
| Cherrier, F | 2 |
| Pernot, C | 3 |
| Yamamoto, T | 1 |
| Yeh, SJ | 1 |
| Lin, FC | 1 |
| Wu, DL | 1 |
| Munkenbeck, FC | 1 |
| Bump, TE | 1 |
| Arzbaecher, RC | 1 |
| Daubert, C | 1 |
| Ollitrault, J | 1 |
| Descaves, C | 1 |
| Mabo, P | 1 |
| Ritter, P | 1 |
| Gouffault, J | 1 |
| Satoh, M | 1 |
| Funazaki, T | 1 |
| Ebe, K | 1 |
| Miyajima, S | 1 |
| Suzuki, K | 1 |
| Aizawa, M | 1 |
| Shibata, A | 1 |
| Estes, NA | 1 |
| Warin, JF | 1 |
| Haissaguerre, M | 1 |
| Le Métayer, P | 1 |
| Montserrat, P | 1 |
| Dubuc, M | 1 |
| Kus, T | 1 |
| Campa, MA | 1 |
| Lambert, C | 1 |
| Rosengarten, M | 1 |
| Shenasa, M | 1 |
| Fujiseki, Y | 1 |
| Fujino, H | 1 |
| Hattori, M | 1 |
| Kamiya, Y | 1 |
| Nishijima, S | 1 |
| Umemura, N | 1 |
| Shimada, M | 1 |
| Sugiyama, T | 1 |
| Matsukawa, S | 1 |
| Nishikawa, R | 1 |
| Costantini, M | 1 |
| Zardini, M | 1 |
| Guasti, L | 1 |
| Swerdlow, CD | 1 |
| Peterson, J | 1 |
| Liem, LB | 1 |
| Szabo, TS | 1 |
| Sharma, AD | 1 |
| Milstein, S | 1 |
| Niazi, I | 1 |
| Naccarelli, GV | 1 |
| Tchou, P | 1 |
| Rinkenberger, R | 1 |
| Dougherty, AH | 1 |
| Jazayeri, M | 1 |
| Fujiki, A | 1 |
| Yoshida, S | 1 |
| Tani, M | 1 |
| Sasayama, S | 1 |
| Inoue, H | 1 |
| Zipes, DP | 1 |
| Admant, P | 1 |
| Le Helloco, A | 1 |
| Robinson, SJ | 1 |
| Dhingra, RC | 1 |
| Rosen, KM | 2 |
| Denes, P | 1 |
| Massumi, RA | 1 |
| Vera, Z | 1 |
| Mason, DT | 1 |
| Bleecker, ER | 1 |
| Engel, BT | 1 |
| Coumel, P | 1 |
| Krikler, D | 1 |
| Slama, R | 1 |
| Bouvrain, Y | 1 |
| Pernod, J | 1 |
| Ferrane, J | 1 |
| Quinot, B | 1 |
| Vasile, N | 1 |
| Carre, R | 1 |
7 reviews available for isoproterenol and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Wolff-Parkinson-White syndrome: lessons learnt and lessons remaining.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Death, Sudden, Cardiac; E | 2017 |
[Wolff-Parkinson-White syndrome (WPW) and current approaches to diagnosis and treatment].
Topics: Anti-Arrhythmia Agents; Atropine; Bundle of His; Electric Countershock; Electrocardiography; Evaluat | 1979 |
[Significance of tachycardia induced by atrial stimulation in Wolff-Parkinson-White syndrome].
Topics: Atrial Fibrillation; Cardiac Pacing, Artificial; Heart Atria; Humans; Isoproterenol; Tachycardia; Wo | 1992 |
[Induction of supraventricular tachycardia (paroxysmal junctional tachycardia and atrial tachycardia) by esophageal stimulation].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Child; Electric Stimulation; | 1990 |
[Should the Isuprel test be performed systematically in Wolff-Parkinson-White syndrome?].
Topics: Adolescent; Adult; Aged; Child; Humans; Isoproterenol; Middle Aged; Prognosis; Wolff-Parkinson-White | 1988 |
Treatment of cardiac arrhythmias.
Topics: Adams-Stokes Syndrome; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; | 1964 |
His bundle electrograms: clinical applications.
Topics: Action Potentials; Arrhythmias, Cardiac; Atrioventricular Node; Atropine; Bundle of His; Cardiac Cat | 1974 |
1 trial available for isoproterenol and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome.
Topics: Adult; Cardiac Pacing, Artificial; Clinical Trials as Topic; Double-Blind Method; Electrophysiology; | 1989 |
50 other studies available for isoproterenol and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Electrophysiological guided accessory-pathway ablation strategy in children with asymptomatic WPW: it may not be enough to prevent sudden cardiac death.
Topics: Accessory Atrioventricular Bundle; Atrial Fibrillation; Catheter Ablation; Child; Death, Sudden, Car | 2023 |
Isoprenaline infusion during EP test in asymptomatic Wolff-Parkinson-White: Are we using the optimal threshold value?
Topics: Asymptomatic Diseases; Electrophysiologic Techniques, Cardiac; Humans; Infusions, Intravenous; Isopr | 2021 |
Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern.
Topics: Adolescent; Adrenergic beta-Agonists; Catheter Ablation; Child; Czech Republic; Electrocardiography; | 2014 |
Guidelines for management of asymptomatic ventricular pre-excitation: brave new world or Pandora's box?
Topics: Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Male; Risk | 2014 |
Decremental accessory pathway conduction after ablation and antidromic atrioventricular reciprocating tachycardia 8 years after successful radiofrequency ablation.
Topics: Action Potentials; Adolescent; Adrenergic beta-Agonists; Atrioventricular Node; Bundle of His; Cathe | 2009 |
Catecholamine challenge unmasking high-risk features in the Wolff-Parkinson-White syndrome.
Topics: Adrenergic beta-Agonists; Catecholamines; Death, Sudden, Cardiac; Electrocardiography; Exercise Test | 2009 |
Isoproterenol administration during general anesthesia for the evaluation of children with ventricular preexcitation.
Topics: Accessory Atrioventricular Bundle; Adolescent; Anesthesia, General; Cardiac Catheterization; Cardiot | 2011 |
Wolff-Parkinson-White syndrome and isoproterenol testing in children: a valid adjunct to predict risk?
Topics: Adolescent; Cardiac Catheterization; Cardiotonic Agents; Catheter Ablation; Child; Child, Preschool; | 2011 |
Development of rapid preexcited ventricular response to atrial fibrillation in a patient with intermittent preexcitation.
Topics: Accessory Atrioventricular Bundle; Adrenergic beta-Agonists; Atrial Fibrillation; Catheter Ablation; | 2013 |
Catecholamine dependent accessory pathway automaticity.
Topics: Adult; Catecholamines; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardia | 2004 |
[Respective interest of two techniques of electrophysiological study in patient without heart disease].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Cardiotonic Agents; Catheter Ablation; Child; Cost Savings | 2006 |
Interest of non-invasive and semi-invasive testings in asymptomatic children with pre-excitation syndrome.
Topics: Adolescent; Adult; Atrial Fibrillation; Cardiology; Child; Death, Sudden, Cardiac; Electrophysiologi | 2007 |
Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
Topics: Ajmaline; Amiodarone; Atrial Fibrillation; Benzofurans; Electrophysiology; Heart; Humans; Isoprotere | 1983 |
Blocking effect of verapamil on conduction over a catecholamine-sensitive bypass tract in exercise-induced Wolff-Parkinson-White syndrome.
Topics: Adult; Cardiac Pacing, Artificial; Catecholamines; Electrocardiography; Exercise Test; Female; Heart | 1984 |
Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
Topics: Atrial Fibrillation; Exercise Test; Humans; Isoproterenol; Risk; Ventricular Fibrillation; Wolff-Par | 1983 |
[Effects of isoproterenol in Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Atrioventricular Node; Bundle of His; Child; Electric Stimulation; Electrocardiog | 1980 |
Unmasking of ventricular preexcitation by vagal stimulation or isoproterenol administration.
Topics: Adult; Ajmaline; Amiodarone; Female; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Mal | 1980 |
Inducible ventricular tachyarrhythmia in children with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Age Factors; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Child; Chi | 1994 |
Comparison of the effects of exercise and isoproterenol on the antegrade refractory period of the accessory pathway in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Exercise Test; Female; Heart Conduction System; Humans; Infusions, Parenter | 1994 |
Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular N | 1996 |
Wide QRS complex tachycardia in the presence of preexcitation: a diagnostic challenge.
Topics: Adenosine; Adult; Cardiac Pacing, Artificial; Catheter Ablation; Electrocardiography; Female; Heart | 1997 |
AV reentrant and idiopathic ventricular double tachycardias: complicated interactions between two tachycardias.
Topics: Adrenergic beta-Antagonists; Catheter Ablation; Humans; Isoproterenol; Male; Middle Aged; Tachycardi | 1999 |
Manifestation of the Wolff-Parkinson-White syndrome during isoprenaline infusion and carotid sinus massage.
Topics: Carotid Sinus; Female; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Middle Aged; Wolf | 1976 |
Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Conductio | 1992 |
Electrophysiological and electropharmacological studies in pre-excitation syndromes: results with propafenone therapy and isoproterenol infusion testing.
Topics: Adrenergic beta-Antagonists; Adult; Cardiac Pacing, Artificial; Drug Therapy, Combination; Female; F | 1992 |
Retrograde supernormal conduction, gap phenomenon in concealed accessory atrioventricular pathways.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Heart Condu | 1992 |
Comparison of isoproterenol and exercise tests in asymptomatic subjects with Wolff-Parkinson-White syndrome.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrophysiology; Exercise Test; Heart Cond | 1992 |
Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Topics: Adolescent; Adult; Atropine; Electrocardiography; Female; Heart Conduction System; Heart Rate; Human | 1992 |
[Electrophysiological characteristics of asymptomatic Wolff-Parkinson-White syndromes].
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Electrophy | 1991 |
Electrophysiologic effects of intravenous propafenone at rest, during isoproterenol infusion and during exercise in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Atrioventricular Node; Cardiac Catheterization; Electrocardiography; Electrophysi | 1991 |
Effects of isoproterenol on accessory pathway conduction in intermittent or concealed Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Conduction S | 1990 |
Differentiation of sinus tachycardia from paroxysmal 1:1 tachycardias using single late diastolic atrial extrastimuli.
Topics: Adolescent; Adult; Aged; Atropine; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart At | 1986 |
Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome.
Topics: Adult; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Exercise Test; Female; He | 1988 |
Electrophysiologic evaluation of asymptomatic patients with the Wolff-Parkinson-White pattern.
Topics: Adult; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Heart Conduction | 1989 |
Reversal of electrophysiologic effects of flecainide on the accessory pathway by isoproterenol in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Electrophysiology; Female; Flecainide; Follow-Up Studies; Humans; Isoproterenol; | 1989 |
[Wolf-Parkinson-White syndrome. Intensive physical activity: the value of fulguration].
Topics: Arrhythmias, Cardiac; Electric Countershock; Electrocardiography; Humans; Isoproterenol; Physical Ex | 1989 |
[Electrophysiologic effects of isoproterenol in children with Wolff-Parkinson-White syndrome].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Electrophysiology; Female; Heart Conduction System | 1989 |
[An electrophysiologic and electropharmacological study of functional properties of the bundle of Kent in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Electrophysiology; Heart Conduction System; Humans; Isoproterenol; Wolff-Parkinson-White S | 1989 |
Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Drug Therapy, C | 1988 |
Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern.
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Death, Sudden; Electrophysiology; Evaluation Studies a | 1989 |
Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
Topics: Administration, Oral; Adult; Anilides; Anti-Arrhythmia Agents; Electrophysiology; Encainide; Female; | 1988 |
Intermittent Wolff-Parkinson-White syndrome due to phase 3 and phase 4 block: disappearance of rapid ventricular response during atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Heart Block; Heart Condu | 1988 |
Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
Topics: Animals; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Dogs; Electrocardiography; | 1987 |
Loss of efficacy of flecainide in the Wolff-Parkinson-White syndrome after isoproterenol administration.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Flecainide; Heart Block; Heart Conductio | 1985 |
[Group discussion: progress in cardiopathology].
Topics: Adrenergic beta-Antagonists; Coronary Angiography; Coronary Vessels; Extracorporeal Circulation; Glu | 1971 |
His-bundle electrography. Clinical applications. Second of two parts.
Topics: Atrioventricular Node; Bundle of His; Digitalis; Electrocardiography; Glucagon; Heart Conduction Sys | 1974 |
The Wolff-Parkinson-White syndrome. A new look at an old problem.
Topics: Atropine; Bundle-Branch Block; Electrocardiography; Heart Conduction System; Humans; Injections, Int | 1973 |
Learned control of cardiac rate and cardiac conduction in the Wolff-Parkinson-White syndrome.
Topics: Adult; Atropine; Conditioning, Operant; Electrocardiography; Female; Heart Conduction System; Heart | 1973 |
Proceedings: Anomalous atrioventricular conduction associated with complete block of the nodal-His pathway: an electrocardiographic study.
Topics: Ajmaline; Electrocardiography; Heart Block; Heart Conduction System; Humans; Isoproterenol; Wolff-Pa | 1974 |
[Obstructive cardiomyopathy and Wolff-Parkinson-White syndrome].
Topics: Adult; Angiocardiography; Cardiomyopathy, Hypertrophic; Humans; Isoproterenol; Male; Radiography; Wo | 1966 |